e.l.f. Beauty Insider Sale: 13,515 Shares Sold Under 10b5-1 Plan
Rhea-AI Filing Summary
Officer sale under 10b5-1 plan: Kory Marchisotto, Senior Vice President and Chief Marketing Officer of e.l.f. Beauty, Inc. (ELF), reported the sale of 13,515 shares of the issuer's common stock on 09/12/2025 at a weighted-average price of $140.1019 per share. The filer states the transaction was made pursuant to a 10b5-1 trading plan adopted on December 10, 2024, and that execution occurred in multiple trades at prices ranging from $140.00 to $140.58. After the sale, the reporting person beneficially owned 144,788 shares, which include 47,398 restricted stock units.
Positive
- Transaction executed under an established 10b5-1 plan, indicating it was pre-arranged and not an ad hoc insider sale
- Filer discloses willingness to provide detailed trade breakdowns by price, supporting transparency
Negative
- Insider disposed of 13,515 shares, reducing beneficial ownership to 144,788 shares
- Sale executed at prices between $140.00 and $140.58, reflecting realized insider selling at current market levels
Insights
TL;DR: Officer sold a small portion of holdings under a pre-established 10b5-1 plan; remaining position includes substantial RSUs.
The Form 4 shows a planned sale executed under a 10b5-1 trading plan, which typically signals a pre-arranged disposition rather than ad hoc insider trading. The sale of 13,515 shares at a weighted-average price of $140.1019 reduced total beneficial ownership to 144,788 shares, and the filing specifies that 47,398 of those are restricted stock units. The report discloses execution across multiple price points between $140.00 and $140.58 and offers to provide a breakdown of quantities at each price upon request. This is a routine disclosure that increases transparency about insider liquidity but does not itself provide forward-looking information about company performance.
TL;DR: Transaction documented and signed by attorney-in-fact; 10b5-1 adoption date disclosed for compliance context.
The filing identifies the reporting person as an officer (Senior VP, Chief Marketing Officer) and includes a clear compliance note that the sale was made pursuant to a 10b5-1 plan adopted on December 10, 2024. The form is signed by an attorney-in-fact, indicating procedural adherence. The disclosure that the filer will provide specifics of trade quantities by price upon request supports recordkeeping and regulatory transparency. From a governance perspective, the Form 4 appears complete and conforms to Section 16 reporting requirements.